Angelmicins, new inhibitors of oncogenic src signal transduction.
Uehara
Y
Y
Li
P M
PM
Fukazawa
H
H
Mizuno
S
S
Nihei
Y
Y
Nishio
M
M
Hanada
M
M
Yamamoto
C
C
Furumai
T
T
Oki
T
T
D016475:3T3 Cells; D000818:Animals; D000880:Anthraquinones / Q000494:pharmacology*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D016391:Genes, src; D051379:Mice; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D015398:Signal Transduction / Q000187:drug effects*
D000880:Anthraquinones; D000903:Antibiotics, Antineoplastic; C083655:angelmicin B; C083653:angelmicin A; D011505:Protein-Tyrosine Kinases